
|Videos|December 3, 2021
Dr. Eggener on active surveillance: “There’s superb long-term outcomes”
Author(s)Urology Times staff
"It’s an important topic to debate,” says Scott E. Eggener, MD.
Advertisement
In this video, Scott Eggener, MD, discusses the key points of the debate, “What is the Preferred Approach for Low Risk Prostate Cancer?” being presented today at the 2021 Society of Urologic Oncology Annual Meeting. Eggener is a Bruce and Beth White Family professor of surgery and radiology, vice chair of the section of urology, and director of the High Risk and Advanced Prostate Cancer Clinic at the University of Chicago Medical Center in Chicago, Illinois.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Practical uses of AI across the urologic care continuum
2
Study progresses of nogapendekin alfa inbakicept for BCG-naïve NMIBC
3
The UroOnc Minute: Diet and Prostate Cancer, with Stephen J. Freedland, MD
4
Walter Hsiang, MD, discusses insurance-related barriers to kidney stone care
5



















